RE:RE:RE:RE:RE:Labs will become king The key in all of this isn't how many agreements they have, rather, it's how much fulfilment to those agreements.
They've done decent signing these things, now it's execution time. No point in signing anything if your partner doesn't want to dance.
Stada looks like it's taken shipment, and if they do their thing, then this year may well be much better than the last couple. Certainly wouldn't make me cry if we went to $4.
NoRiskNoReward wrote: Yes I realize outstanding shares have doubled. But your number are a bit off. Revenue in 2019 was 130mill and the share price hit $7. The profit margins on that were small due to selling wholesale bulk concentrate.
if we go off there shitty 2020 Q4 and they increase each quarter by 25% all the way to 2022 Q1. That would be roughly 18 million with way higher margins. At which they would be on pace to have $80 mill to $100 mill revenue in 2022.
so yes I do predict $4 by next summer. GLTY!